VNS study links 69 per cent response in Depression Treatment

A U.S. study in depression treatment found vagus nerve stimulation helped 69 per cent of active-device patients with severe treatment-resistant depression.

Published
2 Min Read
15 Views
VNS study links 69 per cent response in Depression Treatment

A U.S. study in depression treatment found that vagus nerve stimulation was linked to long-lasting relief for some people with severe treatment-resistant depression. The study followed 493 adults from across the United States and reported that 69 per cent of those with active stimulation improved.

- Advertisement -

International Journal of Neuropsychopharmacology study

The study, published in the International Journal of Neuropsychopharmacology, focused on adults whose depression had not improved after years of treatment. Every participant had already tried at least four different treatments without success, and the average participant had tried 13 different treatments before joining the study.

Researchers monitored symptoms, quality of life and the ability to carry out everyday activities over time. That gave them a broader readout than symptom scores alone, since severe depression can affect work, education, relationships and routine daily tasks.

VNS device placement

Vagus nerve stimulation uses mild electrical signals to stimulate the vagus nerve. Doctors surgically place a small device beneath the skin in the upper chest during the procedure, then connect it to the left vagus nerve in the neck by a thin wire.

Once switched on, the device sends gentle electrical pulses at regular intervals. During the first year of the study, half of the implanted devices were switched on while the others remained inactive and served as a comparison group.

- Advertisement -

VNS benefits and limits

The 69 per cent response rate came from the active-device group, showing benefit for some patients rather than all of them. The comparison setup matters because it gives a baseline against which later changes can be judged, but the published facts do not provide the inactive group’s outcome in that first year.

The study points to a possible option for people who have already cycled through multiple treatments without relief. It also leaves one practical question open: how durable the benefit was beyond the study period and whether the inactive comparison group ended up with similar outcomes.

Advertisement
Share This Article
Investigative news reporter specialising in local government, public policy, and social issues. Two-time Regional Press Award winner.